International Trade Bulletin - Volume 1, Issue 4
Client Alert | 1 min read | 05.01.06
Inside this issue:
- CHINA IN THE SPOTLIGHT
- Intellectual Property: The U.S. and Japan recently announced a joint initiative to strengthen the protection and enforcement of intellectual property rights (IPR) in China and other third countries
- Market Access: The World Trade Organization completed its first Trade Policy Review report of China which concludes that, although China has achieved success in its trade and investment reforms, it still faces challenges
- EUROPE IN THE SPOTLIGHT
- Customs: The recent EU WTO "victory" over the U.S. on customs practices in Europe may seem like a blow to businesses facing customs clearance problems in the EU
- Counterfeit: The EU is to introduce harmonized criminal sanctions and heavy fines for infringements of intellectual property rights throughout the EU
- BILATERAL TRADE: Cross Lander's Investment in Romanian Auto Company Hits Rocky Terrain
- INVESTMENT: Representative Edward Markey, member of the House Homeland Security Committee, announces his intention to introduce an amendment to the Safe Ports Bill requiring inspection of all cargo coming into U.S. seaports
- TRADE REMEDIES: Is Zeroing Finally Dead?
- EXPORT CONTROLS: Recent Cancelled Sale of U.S. Computer Technology to China Highlights Concern over New Planned “Catch-All” Export Rule
- TRADE RETALIATION: The EU imposes punitive duties on eight additional U.S. products as retaliation against the U.S. Byrd law
Contacts
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry
